![Michael Baker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Baker
Chief Executive Officer at
PERCHERON THERAPEUTICS LIMITED
Net worth: 351 933 $ as of 30/08/2026
Profile
Dr. Michael Baker is a Chief Executive Officer & Managing Director at Percheron Therapeutics Ltd. and an Investment Associate at Bioscience Managers Pty Ltd. He is on the Board of Directors at Radiopharm Theranostics (USA), Inc. Dr. Baker was previously employed as an Independent Non-Executive Director by Radiopharm Theranostics Ltd., a Chief Executive Officer, MD & Director by Arovella Therapeutics Ltd., and a Senior Manager by Hexima Ltd. He received his undergraduate degree from La Trobe University, a graduate degree from La Trobe University and an MBA from Melbourne Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 03/05/2026 | 8,184,493 ( 0.68% ) | 351 933 $ | 30/08/2026 |
Michael Baker active positions
| Companies | Position | Start |
|---|---|---|
| PERCHERON THERAPEUTICS LIMITED | Chief Executive Officer | 04/10/2026 |
Bioscience Managers Pty Ltd.
 Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Private Equity Analyst | 31/10/2017 |
Radiopharm Theranostics (USA), Inc.
 Radiopharm Theranostics (USA), Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical products for diagnostic and therapeutic uses | Director/Board Member | - |
Former positions of Michael Baker
| Companies | Position | End |
|---|---|---|
| AROVELLA THERAPEUTICS LIMITED | Chief Executive Officer | 03/05/2026 |
| RADIOPHARM THERANOSTICS LIMITED | Director/Board Member | 25/03/2024 |
| HEXIMA LIMITED | Corporate Officer/Principal | - |
Training of Michael Baker
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
70
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Percheron Therapeutics Ltd.
 Percheron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes antisense pharmaceuticals | Health Technology |
Melbourne Business School
 Melbourne Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hexima Ltd.
 Hexima Ltd. BiotechnologyHealth Technology Engages in research and development of plant-derived proteins for treatment of fungal nail infections and provides commercial property services | Health Technology |
Arovella Therapeutics Ltd.
 Arovella Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and distributes medical devices and consumables | Health Technology |
LaTrobe University
 LaTrobe University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bioscience Managers Pty Ltd.
Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Finance |
Radiopharm Theranostics Ltd.
 Radiopharm Theranostics Ltd. Medical/Nursing ServicesHealth Services Provides nuclear diagnostic services | Health Services |
Radiopharm Theranostics (USA), Inc.
Radiopharm Theranostics (USA), Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical products for diagnostic and therapeutic uses | Health Technology |
- Stock Market
- Insiders
- Michael Baker
